Filing Details

Accession Number:
0001209191-16-135724
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-05 17:01:46
Reporting Period:
2016-08-03
Filing Date:
2016-08-05
Accepted Time:
2016-08-05 17:01:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591213 A Paul Foster C/O Xencor, Inc.
111 West Lemon Avenue
Monrovia CA 91016
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-03 5,000 $4.25 7,419 No 4 M Direct
Common Stock Disposition 2016-08-03 5,000 $20.01 2,419 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-08-03 5,000 $0.00 5,000 $4.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,778 2023-09-03 No 4 M Direct
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
  2. 25% of the shares subject to the option shall vest on the one year anniversary of September 4, 2013 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.